{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:09:37Z","timestamp":1795147777495,"version":"4.10.3"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA255240"],"award-info":[{"award-number":["R01CA255240"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA272827"],"award-info":[{"award-number":["R01CA272827"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA014089"],"award-info":[{"award-number":["P30CA014089"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA316597"],"award-info":[{"award-number":["R01CA316597"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic inflammation increases with age and contributes to cancer progression and therapeutic resistance, yet the mechanisms underlying this process remain incompletely understood. Here, we identify an increased frequency of pro-inflammatory myeloid cells in aged mice and humans, characterized by elevated production of IL-1\u03b1, IL-1\u03b2, IL-6, and TNF-\u03b1. These cells are enriched in the breast tumor microenvironment and are associated with accelerated tumor progression. Using heterochronic parabiosis and bone marrow chimeras, we show that age-associated myeloid cell inflammatory activation is suppressed by non-bone marrow-derived circulating factors present in young hosts. Integrative analyses identify thymulin, a thymus-derived peptide that declines with age, as a mediator that suppresses pro-inflammatory cytokine production by inhibiting NF-\u03baB signaling. Furthermore, thymulin enhances antitumor T-cell immunity, improves tumor control and survival, and sensitizes tumors to anti-PD-L1 therapy in an age-dependent manner. Together, these findings uncover a thymus\u2013myeloid cell regulatory axis linking aging, inflammation, and cancer immunity, and suggest thymulin as a potential strategy to improve cancer immunotherapy in older individuals.<\/jats:p>","DOI":"10.1038\/s41467-026-75383-0","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:02:29Z","timestamp":1784624549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3725-6213","authenticated-orcid":false,"given":"Hisashi","family":"Kanemaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3495-1632","authenticated-orcid":false,"given":"Steven","family":"Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4422-2049","authenticated-orcid":false,"given":"Yukari","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6866-671X","authenticated-orcid":false,"given":"Fumito","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"75383_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"75383_CR2","doi-asserted-by":"crossref","unstructured":"Dolan, M., Libby, K. A., Ringel, A. E., van Galen, P. & McAllister, S. S. Ageing, immune fitness and cancer. Nat. Rev. Cancer 25, 848\u2013872 (2025).","DOI":"10.1038\/s41568-025-00858-z"},{"key":"75383_CR3","doi-asserted-by":"crossref","unstructured":"Terekhova, M., Bohacova, P. & Artyomov, M. N. Human immune aging. Immunity 58, 2646\u20132669 (2025).","DOI":"10.1016\/j.immuni.2025.10.009"},{"key":"75383_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41577-021-00646-4","volume":"22","author":"DA Mogilenko","year":"2022","unstructured":"Mogilenko, D. A., Shchukina, I. & Artyomov, M. N. Immune ageing at single-cell resolution. Nat. Rev. Immunol. 22, 484\u2013498 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"75383_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2022.11.005","volume":"35","author":"S Han","year":"2023","unstructured":"Han, S., Georgiev, P., Ringel, A. E., Sharpe, A. H. & Haigis, M. C. Age-associated remodeling of T cell immunity and metabolism. Cell Metab. 35, 36\u201355 (2023).","journal-title":"Cell Metab."},{"key":"75383_CR6","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi, C., Garagnani, P., Parini, P., Giuliani, C. & Santoro, A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat. Rev. Endocrinol. 14, 576\u2013590 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"75383_CR7","doi-asserted-by":"crossref","unstructured":"Singh, A. et al. Aging and Inflammation. Cold Spring Harb. Perspect. Med. 14, a041197 (2024).","DOI":"10.1101\/cshperspect.a041197"},{"key":"75383_CR8","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.ccell.2025.04.007","volume":"43","author":"H Garner","year":"2025","unstructured":"Garner, H. et al. Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread. Cancer Cell 43, 1279\u20131295.e1279 (2025).","journal-title":"Cancer Cell"},{"key":"75383_CR9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","volume":"24","author":"MA Harris","year":"2024","unstructured":"Harris, M. A. et al. Towards targeting the breast cancer immune microenvironment. Nat. Rev. Cancer 24, 554\u2013577 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"75383_CR10","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1182\/blood-2004-07-2599","volume":"105","author":"L Ferrucci","year":"2005","unstructured":"Ferrucci, L. et al. The origins of age-related proinflammatory state. Blood 105, 2294\u20132299 (2005).","journal-title":"Blood"},{"key":"75383_CR11","doi-asserted-by":"crossref","unstructured":"Laino, A. S. et al. Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition. J. Immunother. Cancer 8, e000842 (2020).","DOI":"10.1136\/jitc-2020-000842"},{"key":"75383_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100878","volume":"4","author":"MA Huseni","year":"2023","unstructured":"Huseni, M. A. et al. CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy. Cell Rep. Med. 4, 100878 (2023).","journal-title":"Cell Rep. Med."},{"key":"75383_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ccell.2022.04.004","volume":"40","author":"Y Hailemichael","year":"2022","unstructured":"Hailemichael, Y. et al. Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer Cell 40, 509\u2013523.e506 (2022).","journal-title":"Cancer Cell"},{"key":"75383_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7702","volume":"6","author":"H Tsukamoto","year":"2015","unstructured":"Tsukamoto, H., Senju, S., Matsumura, K., Swain, S. L. & Nishimura, Y. IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age. Nat. Commun. 6, 6702 (2015).","journal-title":"Nat. Commun."},{"key":"75383_CR15","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1158\/0008-5472.CAN-18-0118","volume":"78","author":"H Tsukamoto","year":"2018","unstructured":"Tsukamoto, H. et al. Combined blockade of IL6 and PD-1\/PD-L1 signaling abrogates mutual regulation of their immunosuppressive effects in the tumor microenvironment. Cancer Res. 78, 5011\u20135022 (2018).","journal-title":"Cancer Res."},{"key":"75383_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54512-7","volume":"15","author":"J Paczkowska","year":"2024","unstructured":"Paczkowska, J. et al. Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma. Nat. Commun. 15, 10740 (2024).","journal-title":"Nat. Commun."},{"key":"75383_CR17","doi-asserted-by":"publisher","first-page":"eadn0327","DOI":"10.1126\/science.adn0327","volume":"386","author":"MD Park","year":"2024","unstructured":"Park, M. D. et al. Hematopoietic aging promotes cancer by fueling IL-1\u03b1-driven emergency myelopoiesis. Science 386, eadn0327 (2024).","journal-title":"Science"},{"key":"75383_CR18","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.immuni.2013.02.007","volume":"38","author":"M Sade-Feldman","year":"2013","unstructured":"Sade-Feldman, M. et al. Tumor necrosis factor-\u03b1 blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity 38, 541\u2013554 (2013).","journal-title":"Immunity"},{"key":"75383_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02358-7","volume":"8","author":"F Bertrand","year":"2017","unstructured":"Bertrand, F. et al. TNF\u03b1 blockade overcomes resistance to anti-PD-1 in experimental melanoma. Nat. Commun. 8, 2256 (2017).","journal-title":"Nat. Commun."},{"key":"75383_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41514-024-00166-0","volume":"10","author":"FA Lagunas-Rangel","year":"2024","unstructured":"Lagunas-Rangel, F. A. Aging insights from heterochronic parabiosis models. NPJ Aging 10, 38 (2024).","journal-title":"NPJ Aging"},{"key":"75383_CR21","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu, S. Z. et al. A single-cell and spatially resolved atlas of human breast cancers. Nat. Genet. 53, 1334\u20131347 (2021).","journal-title":"Nat. Genet."},{"key":"75383_CR22","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C L\u00f3pez-Ot\u00edn","year":"2013","unstructured":"L\u00f3pez-Ot\u00edn, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194\u20131217 (2013).","journal-title":"Cell"},{"key":"75383_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-017-0006-x","volume":"19","author":"J Nikolich-\u017dugich","year":"2018","unstructured":"Nikolich-\u017dugich, J. The twilight of immunity: emerging concepts in aging of the immune system. Nat. Immunol. 19, 10\u201319 (2018).","journal-title":"Nat. Immunol."},{"key":"75383_CR24","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1038\/s43587-025-00984-1","volume":"5","author":"A Parsons","year":"2025","unstructured":"Parsons, A. et al. Cell populations in human breast cancers are molecularly and biologically distinct with age. Nat. Aging 5, 2546\u20132563 (2025).","journal-title":"Nat. Aging"},{"key":"75383_CR25","doi-asserted-by":"crossref","unstructured":"Jang, I. H., Niedernhofer, L. J., Robbins, P. D. & Camell, C. D. The ageing immune system as a driver of systemic ageing. Nat. Rev. Immunol. 26, 489\u2013506 (2026).","DOI":"10.1038\/s41577-026-01269-3"},{"key":"75383_CR26","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s43587-025-00858-6","volume":"5","author":"S Lore","year":"2025","unstructured":"Lore, S. et al. Replacement as an aging intervention. Nat. Aging 5, 750\u2013764 (2025).","journal-title":"Nat. Aging"},{"key":"75383_CR27","doi-asserted-by":"crossref","unstructured":"Ho, T. T. et al. Aged hematopoietic stem cells are refractory to bloodborne systemic rejuvenation interventions. J. Exp. Med. 218, e20210223 (2021).","DOI":"10.1084\/jem.20210223"},{"key":"75383_CR28","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/ni.1729","volume":"10","author":"AS Dejean","year":"2009","unstructured":"Dejean, A. S. et al. Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells. Nat. Immunol. 10, 504\u2013513 (2009).","journal-title":"Nat. Immunol."},{"key":"75383_CR29","doi-asserted-by":"publisher","first-page":"e0220581","DOI":"10.1371\/journal.pone.0220581","volume":"14","author":"DH Kim","year":"2019","unstructured":"Kim, D. H., Jung, I. H., Kim, D. H. & Park, S. W. Knockout of longevity gene Sirt1 in zebrafish leads to oxidative injury, chronic inflammation, and reduced life span. PLoS ONE 14, e0220581 (2019).","journal-title":"PLoS ONE"},{"key":"75383_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105528","volume":"25","author":"JL Mehl","year":"2022","unstructured":"Mehl, J. L. et al. Blockage of lamin-A\/C loss diminishes the pro-inflammatory macrophage response. iScience 25, 105528 (2022).","journal-title":"iScience"},{"key":"75383_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06728-0","volume":"15","author":"C Ribeiro","year":"2024","unstructured":"Ribeiro, C. et al. Foxo3 regulates cortical and medullary thymic epithelial cell homeostasis with implications in T cell development. Cell Death Dis. 15, 352 (2024).","journal-title":"Cell Death Dis."},{"key":"75383_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010127","volume":"5","author":"JS Hale","year":"2010","unstructured":"Hale, J. S., Frock, R. L., Mamman, S. A., Fink, P. J. & Kennedy, B. K. Cell-extrinsic defective lymphocyte development in Lmna-\/- mice. PLoS ONE 5, e10127 (2010).","journal-title":"PLoS ONE"},{"key":"75383_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.655552","volume":"9","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. Sirt6 regulates the development of medullary thymic epithelial cells and contributes to the establishment of central immune tolerance. Front. Cell Dev. Biol. 9, 655552 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"75383_CR34","doi-asserted-by":"publisher","first-page":"1168186","DOI":"10.3389\/fendo.2023.1168186","volume":"14","author":"W Savino","year":"2023","unstructured":"Savino, W. & Lepletier, A. Thymus-derived hormonal and cellular control of cancer. Front. Endocrinol. 14, 1168186 (2023).","journal-title":"Front. Endocrinol."},{"key":"75383_CR35","first-page":"126","volume":"101","author":"B Safieh-Garabedian","year":"1993","unstructured":"Safieh-Garabedian, B., Ahmed, K., Khamashta, M. A., Taub, N. A. & Hughes, G. R. Thymulin modulates cytokine release by peripheral blood mononuclear cells: a comparison between healthy volunteers and patients with systemic lupus erythematosus. Int. Arch. Allergy Immunol. 101, 126\u2013131 (1993).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"75383_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1749-6632.1975.tb29068.x","volume":"249","author":"JF Bach","year":"1975","unstructured":"Bach, J. F., Dardenne, M., Pleau, J. M. & Bach, M. A. Isolation, biochemical characteristics, and biological activity of a circulating thymic hormone in the mouse and in the human. Ann. N. Y. Acad. Sci. 249, 186\u2013210 (1975).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"75383_CR37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri.2017.142","volume":"18","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi, K. & Karin, M. NF-\u03baB, inflammation, immunity and cancer: coming of age. Nat. Rev. Immunol. 18, 309\u2013324 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"75383_CR38","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1158\/2326-6066.CIR-24-0463","volume":"12","author":"P Georgiev","year":"2024","unstructured":"Georgiev, P. et al. Age-associated contraction of tumor-specific T cells impairs antitumor immunity. Cancer Immunol. Res. 12, 1525\u20131541 (2024).","journal-title":"Cancer Immunol. Res."},{"key":"75383_CR39","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1084\/jem.20131219","volume":"210","author":"MN Bouchlaka","year":"2013","unstructured":"Bouchlaka, M. N. et al. Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy.  J. Exp. Med. 210, 2223\u20132237 (2013).","journal-title":"J. Exp. Med."},{"key":"75383_CR40","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1073\/pnas.1000834107","volume":"107","author":"I Beerman","year":"2010","unstructured":"Beerman, I. et al. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc. Natl. Acad. Sci. USA 107, 5465\u20135470 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75383_CR41","doi-asserted-by":"publisher","first-page":"20012","DOI":"10.1073\/pnas.1116110108","volume":"108","author":"WW Pang","year":"2011","unstructured":"Pang, W. W. et al. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc. Natl. Acad. Sci. USA 108, 20012\u201320017 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75383_CR42","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41586-024-07238-x","volume":"628","author":"JB Ross","year":"2024","unstructured":"Ross, J. B. et al. Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity. Nature 628, 162\u2013170 (2024).","journal-title":"Nature"},{"key":"75383_CR43","doi-asserted-by":"crossref","unstructured":"Oh, J., Wang, W., Thomas, R. & Su, D. M. Thymic rejuvenation via FOXN1-reprogrammed embryonic fibroblasts (FREFs) to counteract age-related inflammation. JCI Insight 5, e140313 (2020).","DOI":"10.1172\/jci.insight.140313"},{"key":"75383_CR44","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1056\/NEJMoa2302892","volume":"389","author":"KA Kooshesh","year":"2023","unstructured":"Kooshesh, K. A., Foy, B. H., Sykes, D. B., Gustafsson, K. & Scadden, D. T. Health consequences of thymus removal in adults. N. Engl. J. Med. 389, 406\u2013417 (2023).","journal-title":"N. Engl. J. Med."},{"key":"75383_CR45","doi-asserted-by":"crossref","unstructured":"Bernatz, S. et al. Thymic health consequences in adults. Nature 652, 986\u2013994 (2026).","DOI":"10.1038\/s41586-026-10242-y"},{"key":"75383_CR46","doi-asserted-by":"crossref","unstructured":"Bernatz, S. et al. Thymic health and immunotherapy outcomes in patients with cancer. Nature 652, 995\u20131003 (2026).","DOI":"10.1038\/s41586-026-10243-x"},{"key":"75383_CR47","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1046\/j.1365-2249.2000.01315.x","volume":"121","author":"R Consolini","year":"2000","unstructured":"Consolini, R., Legitimo, A., Calleri, A. & Milani, M. Distribution of age-related thymulin titres in normal subjects through the course of life. Clin. Exp. Immunol. 121, 444\u2013447 (2000).","journal-title":"Clin. Exp. Immunol."},{"key":"75383_CR48","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0896-8411(92)90152-G","volume":"5","author":"B Safieh-Garabedian","year":"1992","unstructured":"Safieh-Garabedian, B., Kendall, M. D., Khamashta, M. A. & Hughes, G. R. Thymulin and its role in immunomodulation. J. Autoimmun. 5, 547\u2013555 (1992).","journal-title":"J. Autoimmun."},{"key":"75383_CR49","first-page":"173","volume":"66","author":"R Consolini","year":"1986","unstructured":"Consolini, R., Cei, B., Cini, P., Bottone, E. & Casarosa, L. Circulating thymic hormone activity in young cancer patients. Clin. Exp. Immunol. 66, 173\u2013180 (1986).","journal-title":"Clin. Exp. Immunol."},{"key":"75383_CR50","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1080\/08820130802447629","volume":"37","author":"SM Lunin","year":"2008","unstructured":"Lunin, S. M., Khrenov, M. O., Novoselova, T. V., Parfenyuk, S. B. & Novoselova, E. G. Thymulin, a thymic peptide, prevents the overproduction of pro-inflammatory cytokines and heat shock protein Hsp70 in inflammation-bearing mice. Immunol. Invest. 37, 858\u2013870 (2008).","journal-title":"Immunol. Invest."},{"key":"75383_CR51","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ccell.2023.03.006","volume":"41","author":"O Anczuk\u00f3w","year":"2023","unstructured":"Anczuk\u00f3w, O. et al. Challenges and opportunities for modeling aging and cancer. Cancer Cell 41, 641\u2013645 (2023).","journal-title":"Cancer Cell"},{"key":"75383_CR52","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","volume":"152","author":"S Dutta","year":"2016","unstructured":"Dutta, S. & Sengupta, P. Men and mice: relating their ages. Life Sci. 152, 244\u2013248 (2016).","journal-title":"Life Sci."},{"key":"75383_CR53","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.4049\/jimmunol.170.6.3099","volume":"170","author":"M Baccam","year":"2003","unstructured":"Baccam, M., Woo, S. Y., Vinson, C. & Bishop, G. A. CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-kappa B, AP-1, and C\/EBP. J. Immunol. 170, 3099\u20133108 (2003).","journal-title":"J. Immunol."},{"key":"75383_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19192-z","volume":"11","author":"T Oba","year":"2020","unstructured":"Oba, T. et al. Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s. Nat. Commun. 11, 5415 (2020).","journal-title":"Nat. Commun."},{"key":"75383_CR55","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1158\/0008-5472.CAN-21-0939","volume":"81","author":"T Oba","year":"2021","unstructured":"Oba, T., Kajihara, R., Yokoi, T., Repasky, E. A. & Ito, F. Neoadjuvant in situ immunomodulation enhances systemic antitumor immunity against highly metastatic tumors. Cancer Res. 81, 6183\u20136195 (2021).","journal-title":"Cancer Res."},{"key":"75383_CR56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbrc.2022.06.007","volume":"618","author":"Y Yamamoto","year":"2022","unstructured":"Yamamoto, Y. et al. Circulating T cells and resident non-T cells restrict type 2 innate lymphoid cell expansion in the small intestine. Biochem. Biophys. Res. Commun. 618, 93\u201399 (2022).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"75383_CR57","doi-asserted-by":"crossref","unstructured":"Yamauchi, T. et al. CD40 and CD80\/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells. Cancer Immunol. Immunother. 71, 137\u2013151 (2021).","DOI":"10.1007\/s00262-021-02969-6"},{"key":"75383_CR58","doi-asserted-by":"publisher","first-page":"E7331","DOI":"10.1073\/pnas.1708598114","volume":"114","author":"H Kanemaru","year":"2017","unstructured":"Kanemaru, H. et al. Antitumor effect of Batf2 through IL-12 p40 up-regulation in tumor-associated macrophages. Proc. Natl. Acad. Sci. USA 114, E7331\u2013E7340 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75383_CR59","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1126\/science.1164206","volume":"322","author":"K Hildner","year":"2008","unstructured":"Hildner, K. et al. Batf3 deficiency reveals a critical role for CD8\u03b1+ dendritic cells in cytotoxic T cell immunity. Science 322, 1097\u20131100 (2008).","journal-title":"Science"},{"key":"75383_CR60","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1158\/2767-9764.CRC-22-0383","volume":"3","author":"E Abdelfatah","year":"2023","unstructured":"Abdelfatah, E. et al. Predictive and prognostic implications of circulating CX3CR1+ CD8+ T cells in non-small cell lung cancer patients treated with chemo-immunotherapy. Cancer Res. Commun. 3, 510\u2013520 (2023).","journal-title":"Cancer Res. Commun."},{"key":"75383_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21619-0","volume":"12","author":"T Yamauchi","year":"2021","unstructured":"Yamauchi, T. et al. T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors. Nat. Commun. 12, 1402 (2021).","journal-title":"Nat. Commun."},{"key":"75383_CR62","doi-asserted-by":"crossref","unstructured":"Kajihara, R. et al. Divergent transcriptional states and kinetics of circulating tumor-infiltrating lymphocyte repertoires with highly homologous T-cell receptor sequences in a patient during immunotherapy. J. Immunother. Cancer 13, e010092 (2025).","DOI":"10.1136\/jitc-2024-010092"},{"key":"75383_CR63","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/2767-9764.CRC-25-0051","volume":"5","author":"L Polyakov","year":"2025","unstructured":"Polyakov, L. et al. Impact of glucocorticoids on immune checkpoint inhibitor efficacy and circulating biomarkers in non-small cell lung cancer patients. Cancer Res. Commun. 5, 1082\u20131094 (2025).","journal-title":"Cancer Res. Commun."},{"key":"75383_CR64","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer, A., Green, J., Pollard, J. Jr. & Tugendreich, S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30, 523\u2013530 (2014).","journal-title":"Bioinformatics"},{"key":"75383_CR65","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329\u2013337.e324 (2019).","journal-title":"Cell Syst."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75383-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75383-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75383-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:02:48Z","timestamp":1784624568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75383-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75383"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75383-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Fumito Ito: Consulting or Advisory role: Otsuka Pharmaceutical Factory. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6534"}}